Numinus Wellness Inc
Company Profile
Business description
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Contact
801 - 33 Water Street
VancouverBCV6B 1R4
CANT: +1 883 686-4687
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 August 2026
Employees
35
Stocks News & Analysis
stocks
Our top ASX picks in every sector
stocks
Tesla: Shares fall as deliveries come in below consensus
stocks
Will Australia’s dwindling fuel supplies impact this share?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,888.60 | 36.90 | -0.41% |
| CAC 40 | 7,962.39 | 0.00 | 0.00% |
| DAX 40 | 23,168.08 | 130.81 | -0.56% |
| Dow JONES (US) | 46,669.88 | 165.21 | 0.36% |
| FTSE 100 | 10,436.29 | 71.50 | 0.69% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,996.34 | 117.16 | 0.54% |
| Nikkei 225 | 53,342.47 | 71.21 | -0.13% |
| NZX 50 Index | 13,065.87 | 163.72 | 1.27% |
| S&P 500 | 6,611.83 | 29.14 | 0.44% |
| S&P/ASX 200 | 8,694.40 | 35.90 | -0.41% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |